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The effect of extracellular Na+ ([Na+],) removal on agonist-induced granule secretion in platelets in relation to [pH]i and 
[Ca*+k changes was investigated. Substitution of ma+], with choline+ of K+ resulted in a significant enhancement of 5HT 
secretion induced by thrombin, collagen, U46619 and the protein kinase C activators, PMA and diCs. Increases in [Ca”]i 
induced by thrombin and U46619 were slightly inhibited or unaffected in these buffers, but [pH]i increases induced by 
thrombin, U46619, PMA and diCs were abolished and a drop in [pHIi (O.Os-O.1 units below resting) was observed. Al- 
though preincubation with potassium acetate produced a big drop in [pHIi and greatly increased secretion with all the 
agonists, particularly in the absence of [Na+lo clear evidence that [pHIi rises due to Na+/H+ exchange are inhibitory to 
secretion was obtained only with thrombin. Thus, (i) NH&l, which restored the increase in [pHIi in the absence of [Na+le 
reduced the potentiated secretory response to thrombin, (ii) no increase in thrombin-induced secretion was observed when 
Naf was replaced with Lif, which allowed a normal increase in [pH]i and (iii) ethyl isopropyl amiloride (EIPA) abolished 
the [pH]i rise and potentiated thrombin-induced secretion. With collagen and U46619, the results suggest hat removal 
of [Nafle per se rather than inhibition of Na+/H+ exchange results in enhanced secretion. It is concluded that ma+], per 
se and [pH]i elevations via Na+/H+ exchange both have important inhibitory roles in the control of platelet granule 
secretion. 
Na+/H+ exchange; Platelet; Secretion 
1. INTRODUCTION 
Many cells respond to stimulation with activa- 
tion of an Na+/H+ exchanger located in the 
plasma membrane [l-4]. This results in an in- 
crease in the cytosolic pH [pHIi, which can affect 
many intracellular processes and control cellular 
function. Recent work in platelets has suggested an 
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obligatory role for Na+/H+ exchange in 
arachidonate release induced by ‘weak’ agonists 
such as ADP and adrenaline [5-S], as well as a 
potentiatory, if not obligatory, role for the ion-ex- 
change mechanism in agonist-induced calcium 
mobilisation [9- 111. 
As the role of Na+/H+ exchange in the induc- 
tion of platelet granule secretion is not known, we 
have used different approaches, namely, Na+ 
substitutes and [pHIi-altering agents such as am- 
monium chloride (NH&l) and potassium acetate, 
to examine this problem. By correlating the extent 
of secretion with changes in [pH]i and [Ca’+]i, we 
have observed that an elevation in [pH]i via 
Na+/H+ exchange is inhibitory to platelet granule 
secretion under some conditions. 
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2. METHODS 
2.1, Preparation of washed platelet suspensions 2.2. Measurement of [‘“C]5HT secretion 
For all the experiments described, the following standard 
procedure for preparing washed platelet suspensions was used, 
except that labelling of platelets with the various markers was 
carried out at different stages of the washing procedure. 
Citrated blood drawn from apparently healthy volunteers was 
centrifuged at 600 x g for 15 min to obtain platelet-rich plasma 
(PRP). 
[‘?]5HT release was measured 3 min after addition of the 
appropriate agonist by counting the platelet supernatants for 
released radioactivity [ 121. 
2.3. Measurement of fCt?‘]i and [pH]i 
Following acidification of the PRP with 0.1 N citric acid and 
addition of 20 nM PC&, the PRP was centrifuged at 1500 x g 
for 10 min to obtain a pellet which was resuspended in a pH 6.5 
buffer composed of 36 mM citric acid, 5 mM KCl, 0.5 mM 
CaClr, 0.35% bovine serum albumin (BSA), 0.09% glucose, 
0.05 U/ml hirudin (Biopharm, England) and 103 mM 
NaCl/choline chloride/KCl/LiCl (buffer A). Following addi- 
tion of 20 nM PGI2, these suspensions were centrifuged at 
1500 x g for 10 min and the platelet pellets were resuspended 
in a pH 7.4 buffer composed of 10 mM Hepes, 5 mM KCI, 
1 mM MgS04, 1 mM CaCl2, 0.35% BSA, 0.09% glucose, 
0.05 U/ml hirudin and 145 mM NaCl/choline 
chloride/KCl/LiCl (buffer B) at a count of 2-4 x 10’ 
platelets/ml. 
Fluorescence measurements on quin 2 and BCECF-loaded 
platelets (unstirred) and calibration of the quin 2 and BCECF 
signals to calculate [Ca*+]i and [pH]i were carried out essential- 
ly as previously described [9]. Excitation wavelengths for the 
quin 2 and BCECF experiments were respectively 339 and 
490 nM, emission wavelengths respectively 500 and 520 nM. 
Absolute [pH]i values were calculated by using the 
nigericin/KCl method to correct the values obtained from lys- 
ing the platelet suspensions (at pH 6.0-8.0) with digitonin. 
2.4. Measurement of protein phosphorylation 
Loading of platelets with quin 2 and [r4C]5HT was carried 
out by incubating 20/M quin 2 ester (Sigma, England) or 
1 &i/ml [*?]5HT (50 Ci/mmol, Amersham, England) with 
PRP for 30 min at 37°C. For the experiments on [pH]i deter- 
minations and protein phosphorylation, a concentrated platelet 
suspension (lo9 platelets/ml) in buffer A (minus Ca2+ and BSA 
for the phosphorylation experiments) containing Na+, was in- 
cubated with 5 PM bis-(carboxyethyl) carboxy fluorescein 
(BCECF, Calbiochem, England) ester or 0.25 mCi/ml carrier- 
free [“Plorthophosphate for 45 min or 90 min respectively, at 
37°C. At the end of this incubation period, the platelet suspen- 
sion was diluted 2-fold with the same buffer or with buffer A 
containing choline+/K+/Li+, centrifuged at 1500 x g for 
10 min and the pellets were resuspended in buffer B of the ap- 
propriate ionic composition. For all the experiments, the wash- 
Incubations of 32P-labelled platelets containing the various 
additions were terminated with 0.5 vol. of an SDS stopping 
solution (9% SDS, 2-mercaptoethanol, 15& glycerol, 0.186 M 
Tris pH 6.8 and 0.03% bromophenol blue) and subjected to 
SDS polyacrylamide gel electrophoresis (4% stacking and 
7-20% separating els) [12]. Following electrophoresis, dried 
gels were subjected to autoradiography for assessment of 32P- 
labelling in the different protein bands. 
3. RESULTS 
3.1. Effect of [Na+]e removal on 5HT secretion 
induced by various platelet agonists 
Earlier workers [2,9,13] have shown that throm- 
bin as well as protein kinase C activators can 
stimulate the plasma membrane Na+/H+ ex- 
changer and thereby cause an increase in [pH]i. To 
evaluate the role of this exchange mechanism in 
ed platelets were pre-treated with indomethacin (10rM) to 
avoid effects of endogenously formed thromboxane AZ. 
Table 1 
Effect of Na+ removal on agonist-induced [14C]5HT secretion 
[‘“C]SHT secretion (Vo) (means f SE) 
Na+ Choline+ K+ Li+ 
Thrombin (0.05 U/ml) 20.5 f 2.7 34.7 zt 4.1* 45.8 + 3.4** 11.5 + 4.5 
diCs (60 PM) 13.4 + 2.1 49.4 + 2.8’* 32.4 f 2.8** 13.7 f 3.3 
PMA (16 nM) 2.8 f 0.7 12.7 f 1.8’ 8.3 f 0.2* - 
Collagen (20 fig/ml) 22.2 f 1.4 37.1 f 1.9** 52.3 f 2.8** 34.0 + 2.5** 
U46619 (1 PM) 7.8 f 1.8 38.4 + 4.4** 51.4 f 2.1** 42.2 f 1.8** 
Washed platelets resuspended in Hepes (pH 7.4) buffer containing Na+, choline+, K* or 
Li+, and pre-loaded with [r4C]5HT were used in these experiments. The extent of 
[‘4C]5HT released was measured 3 min after addition of the various agents (number of 
determinations, n, in four separate experiments was 12-16). * P <0.01, ** P < 0.001 
compared with the response in Na+ buffer (Student’s t-test for unpaired data) 
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platelet granule secretion, we examined the effect 
of Na+ removal and replacement with two types of 
Na+ substitutes: (i) choline+ and K+, which are not 
transported by the exchanger and cause 
cytoplasmic acidification [2,14]; (ii) Li+, which is 
known to be transported by the exchanger and 
causes cytoplasmic alkalinisation [14]. Table 1 
summarises the effects of 1,2-dioctanoylglycerol 
and phorbol 1Zmyristate 13-acetate (PMA), two 
agents that directly activate protein kinase C in in- 
tact platelets [ 12,151, and agonists acting through 
distinct receptors, namely, thrombin, collagen and 
the thromboxane mimetic, U46619. Essentially, 
replacement of Na+ with choline+ or K+ resulted in 
a significant enhancement of 5HT secretion with 
all agents tested. Additionally, increased secretion 
with collagen and U46619 but not thrombin and 
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diCs was observed in Li+ buffer. To test whether 
prolonged exposure to ions other than Na+ was 
responsible for the enhanced secretion, a concen- 
trated (30-fold) platelet suspension resuspended in 
Na+ buffer was prepared. This was then diluted in 
Na+ or choline+ buffer, and used at various times 
after dilution to monitor agonist-induced secre- 
tion. The final concentration of [Na+le following 
dilution in the choline+ buffer was estimated to be 
approx. 5 mM. It was found that time of exposure 
to the choline+ ion did not influence the secretory 
response to any of the agonists tested. 
3.2. Effect of [Na+le removal on agonist-induced 
[pH]i and [Cd’ ]i changes 
Apart from thrombin, diCs and PMA, which in- 
duced a detectable rise in [pH]i in Na+ buffer 
f--- -==: -I-- _-_- d 
r b 
Lit 
it-===; 1 
Fig. 1. (A) Thrombin and diGinduced [Ca*+]r changes in platelets resuspended in NaC, choline+ and Li+ buffers. (B) Effect of 
thrombin, diCs, NH.&1 and potassium acetate on [pH]i in platelets resuspended in Na+, choline+ and Li+ buffers. Fluorescence 
recordings representing the [Ca’+]i and [pH]r levels are shown. Quin-2-loaded platelets resuspended in the different buffers were used 
for the experiments in panel A. Traces a, b and c in each of the buffer systems represent he effect of 0.05 and 0.2 U/ml thrombin 
and 60 PM diCs, respectively. BCECF-loaded platelets resuspended in the different buffers were used for the experiments in panel B.. 
Traces a, b, c, d in each of the buffer systems represent the effect of thrombin (2 U/ml), diCs (60 PM), NH&l (10 mM) and potassium 
acetate (20 mM). The dashed line above trace d represents the effect of thrombin (0.05 U/ml) addition to platelets treated with 
potassium acetate for 1 min. Addition of thrombin (0.05-2 U/ml) 10 s-l min after NH&l did not affect the NH&l-induced [pH]i 
rise in Na+ or choline+ buffers. 
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(0.05-o. 1 units above resting levels) (fig. lb), 
U46619 (1 ,uM) was also found to consistently elicit 
a small rise in [pH]i (-0.05 units) in Na+ buffer 
(data not shown). Collagen (Horm, lo-20 ,ug/ml), 
however, consistently produced a big drop in 
BCECF fluorescence without a subsequent in- 
crease (data not shown). This was attributed to 
quenching of the BCECF signal by the buffer solu- 
tion in which the collagen was made up. Rises in 
[pH]i with thrombin, diCs, PMA and U46619 were 
also observed in Li+ buffer (data with thrombin 
and diCs in fig.lb). These were indistinguishable 
from the [pH]i rises seen in Na+ buffer. Resting 
[pH]i levels in choline+ and K+ buffer were not 
significantly different to that in Na+ buffer, but all 
agents that caused an increase in [pH]i over resting 
in Na+ buffer, caused a significant drop in [pH]r in 
choline+ or K+ buffer (0.05-0.15 units below 
resting levels, fig. lb). 
over resting in Na+, choline+ and K+ buffer 
respectively). 
3.3. Role of [pH]i in 5HT secretion 
To assess whether changes in [pH]i were respon- 
sible for the potentiated secretory responses een in 
the absence of [Na+],, the effects of NH&I 
(10 mM) and potassium acetate (20 mM), which 
respectively raise and lower [pH]i on their own 
(fig.lb), were tested. NH&l was found to partially 
or totally reverse the potentiated responses to 
thrombin and diCs while not affecting the 
responses to collagen or U46619 in choline+ buffer 
(table 2). Potassium acetate was found to 
significantly enhance 5HT secretion in response to 
all agents, particularly in choline+ buffer, while 
not inducing any secretion on its own. 
3.4. Effect of EIPA on agonist-induced secretion 
Resting [Ca”]i levels were not significantly dif- At concentrations that abolished thrombin and 
ferent in Na+, choline+, K+ or Li+ buffer. [Ca*+]i diCs-induced [pH]i rises (20-50 PM), EIPA 
increases induced by thrombin at the concentration significantly potentiated thrombin but not diCs or 
used for the secretion studies (0.05 U/ml) were collagen-induced secretion (table 3). The poten- 
greatly reduced in choline+ and K+ buffers but tiated response to thrombin in the presence of 
unaffected in Li+ buffer (fig.la). DiCs, PMA and EIPA was partially reversed by NH&l (10 mM) 
collagen induced no increase over the resting addition. EIPA alone caused no change in resting 
[Ca*+]i level in Na+, choline+, K+ or Li+ buffer, [pH]i in Na+ buffer, but in combination with 
while U46619-induced [Ca’+]i rise was unaffected thrombin caused pronounced acidification over a 
or significantly inhibited in choline+ and K+ buffer 4 min incubation (0.1-0.2 units below resting 
respectively (225 + 15, 216 + 21, and 91 f 8 nM levels). No such acidification was observed when 
Table 2 
Effect of NH&l and potassium acetate on agonist-induced [14C]5HT secretion in Na+ and 
choline+ buffer 
[r4C]5HT secretion (qlo) (means + SE) 
Control + NH&l + pot. acetate 
Thrombin (0.05 U/ml) Na+ 20.5 * 2.1 19.8 * 2.5 29.1 + 1.7 
Choline+ 34.7 * 4.1 19.1 + 2.8* 46.6 + 3.9* 
DiCs (60 PM) Na+ 13.4 + 2.1 14.3 + 1.9 21.4 f 3.3 
Choline+ 49.4 f 2.8 39.0 + 2.0* 69.3 f 2.0** 
Collagen (20 rg/ml) Na+ 22.2 f 1.4 19.9 f 1.1 - 
Choline+ 37.1 + 1.9 33.5 f 1.8 _ 
U46619 (1 PM) Na+ 7.8 f 1.8 9.1 f 1.8 47.5 f 3.4** 
Choline+ 38.4 f 4.4 38.9 f 4.3 55.5 k 2.4* 
[r4C]5HT-labelled platelets were pre-incubated with N&Cl (10 mM) or potassium acetate 
(20 mM) for 1 min before addition of the various agents and reactions were terminated 
3 min later (n = 12-16 in four separate xperiments). * P < 0.01, ** P < 0.001 compared 
with the agonist control 
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Table 3 
Effect of EIPA on agonist-induced [14C]5HT secretion 
[i4C]5HT secretion (Vo) 
(means f SE) 
Thrombin 
EIPA + thrombin 
NH&l + EIPA + thrombin 
diCs 
EIPA + diCs 
Collagen 
EIPA + collaeen 
31.1 f 5.4 
64.1 f 2.9* 
42.1 + 4.36** 
12.3 + 1.5 
10.0 1- 1.3 
23.1 * 2.9 
33.3 * 4.7 
EIPA (20 FM) was added 1 min before thrombin (0.05 U/ml), 
collagen (2Opg/ml) or diCs (60pM) and reactions were 
terminated 3 min after addition of the agonist. NH&l (10 mM) 
was added 30 s before EIPA (n = 9-12 from four separate 
experiments). * P < 0.001 compared with thrombin control, 
** P < 0.001 compared with EIPA + thrombin 
EIPA was added along with diCs (results not 
shown). Long incubations with EIPA alone 
(6-8 min) resulted in up to 30% [14C]5HT release; 
hence the pre-incubation time with EIPA was 
limited to 1 min. 
3.5. Effect of [Na+je removal on diC8 and 
thrombin-induced protein phosphorylation 
Contrasting results on diCs and thrombin- 
induced protein phosphorylation were obtained 
abcdetghi jk~mn 
Fig.2. Effect of Naf removal and [pH]r manipulations on 
thrombin and dir&induced protein phosphorylation in 32P- 
labelled platelets. An autoradiograph of a dried gel following 
electrophoresis howing changes in “P-1abelling of different 
proteins is shown. Lanes a and e represent resting platelets in 
choline+ and Na+ buffer, respectively. Lanes b, c, d and f, g, 
h represent in choline+ and Na+ buffer, respectively, the effect 
of diCs (18 pM), NH.&1 (10 mM) + diCs and potassium acetate 
(20 mM) + diCs. Lanes i, j, k and 1, m, n represent in choline+ 
and Naf buffer, respectively, the effect of thrombin 
(0.05 U/ml), NH&l + thrombin and potassium acetate + 
thrombin. N&Cl and potassium acetate were added 1 min 
before diCs and thrombin and reactions were terminated 3 min 
later (similar results were obtained when reactions were 
terminated at 30, 60 and 90 s after addition of thrombin or 
diCs). These agents on their own induced no significant changes 
in 32P-labelling of the different proteins over a 4 min period. 
upon removal of [Na+le. While diCs (18-60 PM)- 
induced 45 kDa protein phosphorylation was un- 
changed by removal of [Na+le i.e. in choline+ buf- 
fer, thrombin (0.05 U/ml)-induced protein 
phosphorylation was significantly reduced (fig.2). 
Preincubation of the platelets with potassium 
acetate (20 mM) for 1 min before addition of diCs 
was found to significantly enhance the extent of 
phosphorylation of the 45 kDa protein in the 
choline+ buffer, and pre-incubation with NH&l 
(10 mM) had no effect. 
4. DISCUSSION 
A great deal of recent interest in cellular signall- 
ing mechanisms has focussed on the Na+/H+ ex- 
change mechanism and the role of elevated [pH]i in 
cellular responses. In platelets, it has been sug- 
gested that Na+/H+ exchange is obligatory in 
arachidonate release induced by ‘weak’ agonists 
[5-81, and potentiatory, if not obligatory, in 
receptor-mediated Ca2+ mobilisation [9-l 11. In 
the present study, we have focussed on platelet 
granule secretion as a potential site for control by 
Na+/H+ exchange, and have found that contrary 
to earlier reports on [pH]i elevations being a 
positive signal in some platelet activation pro- 
cesses, the exchange mechanism is inhibitory to 
platelet granule secretion under some conditions. 
Evidence that this is the case in thrombin-induced 
secretion comes from three of our findings: (i) 
secretion is greatly enhanced in choline+ and K+ 
buffers in the absence of a [pH]i rise and this 
potentiated response is reversed by NH&I, which 
raises [pHIi; (ii) no increase in secretion is seen 
when [Na+le is replaced by Li+, which allows a 
normal agonist-induced [pH]i rise and (iii) EIPA 
inhibits the [pH]i rise and potentiates ecretion. In 
the case of collagen and U46619, the increased 
secretion even in Li+ buffer, the lack of effect of 
NH&l and EIPA suggest that, [Na+le per se, 
rather than Na+/H+ exchange may be the impor- 
tant factor inhibiting secretion. DiCs-induced 
secretion may be modulated by both [Na+le as well 
as Na+/H+ exchange because NH&l partially 
reverses the potentiated response in choline+ buf- 
fer and no increase in secretion is seen in Li+ buf- 
fer, even though EIPA has no potentiatory effect 
on secretion. It is interesting that pre-treatment 
with potassium acetate, which caused a big drop in 
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[pHIi, 
Wa’L namely, protein kinase C-mediated 
phosphorylations and [Ca2+]i, seem unlikely can- 
didates. This is because (i) no significant difference 
in the extent of diGinduced protein phosphoryla- 
tion was observed in Na+ versus choline+ buffer, 
and (ii) thrombin-induced protein phosphorylation 
and [Ca2+]i elevations, in contrast to 5HT secre- 
tion, were significantly reduced in choline+ com- 
pared with Na+ buffer. These two findings suggest 
that although protein kinase C activation per se 
may be unaffected by the absence of [Na+le and an 
intact Na+/H+ exchanger, receptor-mediated pro- 
tein kinase C activation (via diacylglycerol forma- 
tion [l&19]), may be dependent on the presence of 
[Na% and/or an intact Na+/H+ exchanger. 
Studies on thrombin-induced inositol phospholipid 
hydrolysis to test such a possibility are currently in 
progress. The enhanced protein phosphorylation 
in choline+ buffer upon addition of potassium 
acetate may indicate that a large drop in resting 
[pH]i of several units may favour protein kinase C- 
mediated phosphorylation, even though a small 
drop in [pH]i caused by the lack of an intact ex- 
changer may have no effect on it. It is also unlikely 
that changes in membrane depolarization could ac- 
count for the increased secretion, as the responses 
in choline+ and K+ buffer were similar, despite dif- 
ferent depolarisation states in the presence of these 
two ions [20]. 
200 
In conclusion, the present study has revealed 
that [Na+le as well as the Na+/H+ exchange 
mechanism via increased [pH]i can negatively con- 
trol platelet granule secretion; and although the 
site of action of both components is not known at 
present, the exchanger and [Na+le may play a 
similar inhibitory role in other cellular signal 
transduction systems leading to granule exocytosis. 
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